AR043941A1 - DERIVATIVES OF QUINOLINES 4-SUBSTITUTES, THEIR PREPARATION PROCEDURES AND INTERMEDIATES AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM - Google Patents
DERIVATIVES OF QUINOLINES 4-SUBSTITUTES, THEIR PREPARATION PROCEDURES AND INTERMEDIATES AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEMInfo
- Publication number
- AR043941A1 AR043941A1 ARP040101023A ARP040101023A AR043941A1 AR 043941 A1 AR043941 A1 AR 043941A1 AR P040101023 A ARP040101023 A AR P040101023A AR P040101023 A ARP040101023 A AR P040101023A AR 043941 A1 AR043941 A1 AR 043941A1
- Authority
- AR
- Argentina
- Prior art keywords
- heteroaryl
- alkyl
- phenyl
- mono
- cyclic
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229940111121 antirheumatic drug quinolines Drugs 0.000 title 1
- 239000000543 intermediate Substances 0.000 title 1
- 150000003248 quinolines Chemical class 0.000 title 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 13
- -1 4-substituted quinoline Chemical class 0.000 abstract 12
- 125000001072 heteroaryl group Chemical group 0.000 abstract 9
- 125000000217 alkyl group Chemical group 0.000 abstract 8
- 229910052757 nitrogen Inorganic materials 0.000 abstract 7
- 125000003545 alkoxy group Chemical group 0.000 abstract 6
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 6
- 229910052739 hydrogen Inorganic materials 0.000 abstract 6
- 239000001257 hydrogen Substances 0.000 abstract 6
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 6
- 125000004446 heteroarylalkyl group Chemical group 0.000 abstract 5
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 5
- 229910052717 sulfur Inorganic materials 0.000 abstract 5
- 229910003827 NRaRb Inorganic materials 0.000 abstract 4
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 4
- 125000000000 cycloalkoxy group Chemical group 0.000 abstract 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 4
- 150000003254 radicals Chemical class 0.000 abstract 4
- 125000004414 alkyl thio group Chemical group 0.000 abstract 3
- 125000005366 cycloalkylthio group Chemical group 0.000 abstract 3
- 125000005368 heteroarylthio group Chemical group 0.000 abstract 3
- 125000003884 phenylalkyl group Chemical group 0.000 abstract 3
- 125000004434 sulfur atom Chemical group 0.000 abstract 3
- 125000002252 acyl group Chemical group 0.000 abstract 2
- 125000003282 alkyl amino group Chemical group 0.000 abstract 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 2
- 125000005170 cycloalkyloxycarbonyl group Chemical group 0.000 abstract 2
- 125000004786 difluoromethoxy group Chemical group [H]C(F)(F)O* 0.000 abstract 2
- 125000005326 heteroaryloxy alkyl group Chemical group 0.000 abstract 2
- 125000005150 heteroarylsulfinyl group Chemical group 0.000 abstract 2
- 125000005143 heteroarylsulfonyl group Chemical group 0.000 abstract 2
- 125000005842 heteroatom Chemical group 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 abstract 2
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 abstract 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000004423 acyloxy group Chemical group 0.000 abstract 1
- 125000005035 acylthio group Chemical group 0.000 abstract 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 abstract 1
- 125000004644 alkyl sulfinyl group Chemical group 0.000 abstract 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 abstract 1
- 229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000006310 cycloalkyl amino group Chemical group 0.000 abstract 1
- 125000006254 cycloalkyl carbonyl group Chemical group 0.000 abstract 1
- 125000005149 cycloalkylsulfinyl group Chemical group 0.000 abstract 1
- 125000005144 cycloalkylsulfonyl group Chemical group 0.000 abstract 1
- 125000004663 dialkyl amino group Chemical group 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 239000011737 fluorine Substances 0.000 abstract 1
- 125000001188 haloalkyl group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000005241 heteroarylamino group Chemical group 0.000 abstract 1
- 125000005223 heteroarylcarbonyl group Chemical group 0.000 abstract 1
- 125000005553 heteroaryloxy group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000005844 heterocyclyloxy group Chemical group 0.000 abstract 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
- HZVOZRGWRWCICA-UHFFFAOYSA-N methanediyl Chemical class [CH2] HZVOZRGWRWCICA-UHFFFAOYSA-N 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 abstract 1
- 125000005359 phenoxyalkyl group Chemical group 0.000 abstract 1
- 125000004660 phenylalkylthio group Chemical group 0.000 abstract 1
- 125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 abstract 1
- 125000002943 quinolinyl group Chemical class N1=C(C=CC2=CC=CC=C12)* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 abstract 1
- 125000005034 trifluormethylthio group Chemical group FC(S*)(F)F 0.000 abstract 1
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 abstract 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La presente se refiere a derivados de quinolina 4-sustituida procedimiento y composición farmacéutica que la compone. Reivindicación 1: Un derivado de quinolina 4-sustituida, caracterizada porque responde a la fórmula general (1), en la cual: X1, X2, X3, X4 y X5 representan respectivamente >C-R'1 a >CR'5, o bien uno como máximo entre ellos representa un átomo de nitrógeno; R1, R'1, R'2, R'3, R'4 y R'5 son iguales o diferentes y representan un átomo de hidrógeno o de halógeno o un radical alquilo, cicloalquilo, fenilo, feniltio, heteroarilo o heteroariltio mono- o di-cíclico, OH, SH, alquiloxi, difluorometoxi, trifluorometoxi, alquiltio, trifluorometiltio, cicloalquiloxi, cicloalquiltio, acilo, aciloxi, aciltio, ciano, carboxi, alquiloxi, alquiloxicarbonilo, cicloalquiloxicarbonilo, nitro, -NRaRb o -CONRaRb (para los que Ra y Rb pueden representar hidrógeno, alquilo, cicloalquilo, fenilo, heteroarilo mono- o di-cíclico o Ra y Rb forman conjuntamente con el átomo de nitrógeno al que están unidos un heterociclo de 5 ó 6 eslabones que puede contener eventualmente otro heteroátomo escogido entre O, S o N y que porte en su caso un sustituyente alquilo, fenilo o heteroarilo mono- o bi-cíclico en el átomo de nitrógeno o, en su caso, cuyo átomo de azufre esté oxidado al estado sulfinilo o sulfonilo), o representan un radical metileno sustituido con flúor, hidroxi, alquiloxi, alquiltio, cicloalquiloxi, cicloalquiltio, fenilo, heteroarilo mono- o bi-cíclico, carboxi, alquiloxicarbonilo, cicloalquiloxicarbonilo, -NRaRb o -CONRaRb para los que Ra y Rb se definen como anteriormente; O representan fenoxi, heterocicliloxi, benciloxi, heterociclilmetiloxi, o bien R1 puede representar igualmente difluorometoxi o un radical de estructura -CmF2m+1, -SCmF2m+1 o -OcmF2+1 para los que m es un número entero de 1 6 o bien R'5 puede representar igualmente trifluoroacetilo; m es igual a 1, 2 ó 3; n es igual a 0, 1 ó 2; Y representa un grupo CHR, CO, CROH, CRNH2, CRF o CF2, siendo R un átomo de hidrógeno o un radical alquilo (C1-6); Z representa un grupo CH2, o bien Z representa un átomo de oxígeno, un átomo de azufre, un grupo SO o un grupo SO2 y, en su caso, n es igual a 2; R2 representa un radical -CO2R, -CH2CO2R, -CH2-CH2CO2R, -CH2OH o -CH2-CH2OH, siendo R como se definió con anterioridad; R3 representa un radical fenilo, heteroarilo, mono- o bi-cíclico, alk-Ro3 para el que alk es un radical alquileno y Ro3 representa hidrógeno, halógeno, hidroxi, alquiloxi, alquiltio, alquilsulfinilo, alquilsulfonilo, alquilamino, dialquilamino, cicloalquilo, cicloalquiloxi, cicloalquiltio, cicloalquilsulfinilo, cicloalquilsulfonilo, cicloalquilamino, N-cicloalquilo, N-alquil-amino, -N-(cicloalquilo)2, acilo, cicloalquilcarbonilo, fenilo, fenoxi, feniltio, fenilsulfinilo, fenilsulfonilo, fenilamino, N-alquil-N-fenil-amino, N-cicloalquil-N-fenil-amino, -N-(fenilo)2, fenilalquiloxi, fenilalquiltio, fenilalquilsulfinilo, fenilalquilsulfonilo, fenilalquilamino, N-alquil-N-fenil-aminoalquilo, N-cicloalquil-N-fenilalquil-amino, benzoilo, heteroarilo mono- o bi-cíclico, heteroariloxi, heteroariltio, heteroarilsulfinilo, heteroarilsulfonilo, heteroarilamino, N-alquil-N-heteroaril-amino, N-cicloalquil-N-heteroaril-amino, heteroarilcarbonilo, heteroarilalquiloxi, heteroarilalquiloxi, heteroarilalquiltio, heteroarilalquilsulfinilo, heteroarilalquilsulfonilo, heteroarilalquilamino, N-alquil-N-heteroaril-amino-alquilo, N-cicloalquil-N-heteroaril-aminoalquilo (las partes de heteroarilo citadas con anterioridad son mono- o bi-cíclicas), carboxi, alquiloxicarbonilo, -NRaRb o -CO-NRaRb para los que Ra y Rb representan respectivamente hidrógeno, alquilo, cicloalquilo, fenilo, heteroarilo, mono- o bi-cíclico, o uno de Ra o Rb representa hidroxi, alquiloxi, cicloalquiloxi, o Ra y Rb forman conjuntamente con el átomo de nitrógeno al que están unidos un heteroarilo de 5 a 6 escalones que puede contener eventualmente otro heteroátomo escogido entre O, S y N y que porta en su caso un sustituyente alquilo, fenilo o heteroarilo mono- o bi-cíclico sobre el átomo de nitrógeno o, en su caso, cuyo átomo de azufre está oxidado al estado sulfinilo sulfonilo, o bien Ro3 representa -CR'b = CR'c-R'a para el que R'a representa fenilo, fenilalquilo, heteroarilo o heteroarilalquilo cuya parte de heteroarilo es mono- o bi-cíclica, fenoxialquilo, feniltioalquilo, fenilsulfinilalquilo, fenilsulfonilalquilo, fenilaminoalquilo, N-alquil-N-fenil-aminoalquilo, heteroariloxialquilo, heteroariltioalquilo, heteroarilsulfinilalquilo, heteroarilsulfonilalquilo, hetroarilaminoalquilo, N-alquil-N-heteroaril-aminoalquilo, heteroariltio, heteroarilsulfinilo, heteroarilsulfonilo, (las partes de heteroarilo citadas con anterioridad son mono- o bi-cíclicas), feniltio, fenilsulfinilo, fenilsulfonilo, y para los que R'b y R'c representan hidrógeno, alquilo o cicloalquilo, o bien Ro3 representa un radical -C=C-Rd para el que Rd es alquilo, fenilo, fenialquilo, fenoxialquilo, feniltioalquilo, N-alquil-N-fenil-aminoalquilo, heteroarilo mono- o bi-cíclico, heteroarilalquilo, heteroariloxialquilo, heteroariltioalquilo, heteroarilaminoalquilo, N-alquil-N-heteroaril-aminoalquilo (las partes de heteroarilo citadas con anterioridad son aromáticas mono- o bi-cíclicas) o bien Ro3 representa un radical, -CF2-fenilo o -CF2-heteroarilo mono- o bi-cíclico, debiendo entenderse que los radicales o partes de fenilo, bencilo, benzoilo o heteroarilo mencionados con anterioridad están eventualmente sustituidos en el ciclos con 1 a 4 sustituyentes escogidos entre hidrógeno, hidroxi, alquilo, alquiloxi, alquiloxialquilo, halógenoalquilo, trifluorometilo, trifluorometoxi, trifluorometiltio, carboxi, alcoxi-carbonilo, ciano, alquilamino, -NRaRb para el Ra y Rb se definen como anteriormente, fenilo, hidroxialquilo, alquiltioalquilo, alquilsulfinilalquilo, alquilsulfonilalquilo, debiendo entenderse que los radicales y partes de alquilo o acilo contienen (salvo mención especial) C1-10 en una cadena lineal o ramificada y que los radicales cicloalquilo C3-6, en sus formas enantiómeras o diastereosómeras o las mezclas de estas formas, y/o en su caso en forma syn o anti o sus mezclas, así como sus sales.This refers to quinoline derivatives 4-substituted process and pharmaceutical composition that composes it. Claim 1: A 4-substituted quinoline derivative, characterized in that it responds to the general formula (1), in which: X1, X2, X3, X4 and X5 respectively represent> C-R'1 to> CR'5, or well one at most among them represents a nitrogen atom; R1, R'1, R'2, R'3, R'4 and R'5 are the same or different and represent a hydrogen or halogen atom or an alkyl, cycloalkyl, phenyl, phenylthio, heteroaryl or heteroarylthio mono- radical or di-cyclic, OH, SH, alkyloxy, difluoromethoxy, trifluoromethoxy, alkylthio, trifluoromethylthio, cycloalkyloxy, cycloalkylthio, acyl, acyloxy, acylthio, cyano, carboxy, alkyloxy, alkyloxycarbonyl, cycloalkyloxycarbonyl, nitro or -NRaR queb -NRaRb--CRRR -B Ra and Rb may represent hydrogen, alkyl, cycloalkyl, phenyl, mono- or di-cyclic heteroaryl or Ra and Rb together with the nitrogen atom to which a 5 or 6 link heterocycle is attached which may optionally contain another heteroatom chosen from O, S or N and bearing a mono- or bi-cyclic alkyl, phenyl or heteroaryl substituent on the nitrogen atom, or, where appropriate, whose sulfur atom is oxidized to the sulfinyl or sulfonyl state), or represent a substituted methylene radical co n fluorine, hydroxy, alkyloxy, alkylthio, cycloalkyloxy, cycloalkylthio, phenyl, mono- or bi-cyclic heteroaryl, carboxy, alkyloxycarbonyl, cycloalkyloxycarbonyl, -NRaRb or -CONRaRb for which Ra and Rb are defined as above; Or they represent phenoxy, heterocyclyloxy, benzyloxy, heterocyclylmethyloxy, or R1 can also represent difluoromethoxy or a radical of structure -CmF2m + 1, -SCmF2m + 1 or -OcmF2 + 1 for which m is an integer of 1 6 or R '5 may also represent trifluoroacetyl; m is equal to 1, 2 or 3; n is equal to 0, 1 or 2; Y represents a group CHR, CO, CROH, CRNH2, CRF or CF2, where R is a hydrogen atom or a (C1-6) alkyl radical; Z represents a CH2 group, or Z represents an oxygen atom, a sulfur atom, an SO group or an SO2 group and, where appropriate, n is equal to 2; R2 represents a radical -CO2R, -CH2CO2R, -CH2-CH2CO2R, -CH2OH or -CH2-CH2OH, where R is as defined above; R3 represents a phenyl, heteroaryl, mono- or bi-cyclic radical, alk-Ro3 for which alk is an alkylene radical and Ro3 represents hydrogen, halogen, hydroxy, alkyloxy, alkylthio, alkylsulfinyl, alkylsulfonyl, alkylamino, dialkylamino, cycloalkyl, cycloalkyloxy , cycloalkylthio, cycloalkylsulfinyl, cycloalkylsulfonyl, cycloalkylamino, N-cycloalkyl, N-alkyl-amino, -N- (cycloalkyl) 2, acyl, cycloalkylcarbonyl, phenyl, phenoxy, phenylthio, phenylsulfinyl, phenylsulfonyl, phenylamino, N-alkyl-N-alkyl -amino, N-cycloalkyl-N-phenyl-amino, -N- (phenyl) 2, phenylalkylloxy, phenylalkylthio, phenylalkyl sulfyl, phenylalkyl sulfonyl, phenylalkyl amino, N-alkyl-N-phenyl-aminoalkyl, N-cycloalkyl-N-phenylalkyl-amino , benzoyl, mono- or bi-cyclic heteroaryl, heteroaryloxy, heteroarylthio, heteroarylsulfinyl, heteroarylsulfonyl, heteroarylamino, N-alkyl-N-heteroaryl-amino, N-cycloalkyl-N-heteroaryl-amino, heteroarylcarbonyl, heteroarylalkyl, heteroarylalkyl, heteroarylalkyl ilalkylthio, heteroarylalkylsulfinyl, heteroarylalkyl sulfonyl, heteroarylalkylamino, N-alkyl-N-heteroaryl-amino-alkyl, N-cycloalkyl-N-heteroaryl-aminoalkyl (the heteroaryl parts mentioned above are mono- or bi-cyclic), carboxy, alkyloxycarbonyl -NRaRb or -CO-NRaRb for which Ra and Rb respectively represent hydrogen, alkyl, cycloalkyl, phenyl, heteroaryl, mono- or bi-cyclic, or one of Ra or Rb represents hydroxy, alkyloxy, cycloalkyloxy, or Ra and Rb form together with the nitrogen atom to which a 5- to 6-stage heteroaryl is attached, which may optionally contain another heteroatom chosen from O, S and N and which, if appropriate, carries a mono- or bi-cyclic alkyl, phenyl or heteroaryl substituent on the nitrogen atom or, where appropriate, whose sulfur atom is oxidized to the sulfinyl sulfonyl state, or Ro3 represents -CR'b = CR'c-R'a for which R'a represents phenyl, phenylalkyl, heteroaryl or heteroarylalkyl whose p art heteroaryl is mono- or bi-cyclic, phenoxy, phenylthio, fenilsulfinilalquilo, fenilsulfonilalquilo, phenylaminoalkyl, N-alkyl-N-phenylaminoalkyl, heteroaryloxyalkyl, heteroarylthioalkyl, heteroarylsulfinylalkyl, heteroarylsulfonylalkyl, hetroarilaminoalquilo, N-alkyl-N-heteroaryl-aminoalkyl , heteroarylthio, heteroarylsulfinyl, heteroarylsulfonyl, (the parts of heteroaryl mentioned above are mono- or bi-cyclic), phenylthio, phenylsulfinyl, phenylsulfonyl, and for which R'b and R'c represent hydrogen, alkyl or cycloalkyl, or Ro3 represents a radical -C = C-Rd for which Rd is alkyl, phenyl, phenylalkyl, phenoxyalkyl, phenylthioalkyl, N-alkyl-N-phenyl-aminoalkyl, mono- or bi-cyclic heteroaryl, heteroarylalkyl, heteroaryloxyalkyl, heteroarylthioalkyl, heteroarylaminoalkyl , N-alkyl-N-heteroaryl-aminoalkyl (the heteroaryl parts mentioned above are mono- or bi-cyclic aromatic) or Ro3 represents a radical, -CF2-phenyl or -CF2-mono- or bi-cyclic heteroaryl, it being understood that the above-mentioned phenyl, benzyl, benzoyl or heteroaryl radicals or parts are optionally substituted in the cycle with 1 to 4 substituents chosen from hydrogen , hydroxy, alkyl, alkyloxy, alkyloxyalkyl, halogenoalkyl, trifluoromethyl, trifluoromethoxy, trifluoromethylthio, carboxy, alkoxycarbonyl, cyano, alkylamino, -NRaRb for Ra and Rb are defined as above, phenyl, hydroxyalkyl, alkylthioalkylalkyl, alkylalkyl, alkylalkyl, alkylalkyl, alkylsilylalkyl, alkyl it is understood that the alkyl or acyl radicals and parts contain (unless special mention) C1-10 in a linear or branched chain and that the C3-6 cycloalkyl radicals, in their enantiomeric or diastereomeric forms or mixtures of these forms, and / or where appropriate in syn or anti form or their mixtures, as well as their salts.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0303812A FR2852954B1 (en) | 2003-03-28 | 2003-03-28 | QUINOLINE-4-SUBSTITUTED DERIVATIVES, METHODS AND PREPARATION INTERMEDIATES THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR043941A1 true AR043941A1 (en) | 2005-08-17 |
Family
ID=32947235
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP040101023A AR043941A1 (en) | 2003-03-28 | 2004-03-26 | DERIVATIVES OF QUINOLINES 4-SUBSTITUTES, THEIR PREPARATION PROCEDURES AND INTERMEDIATES AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1611127A2 (en) |
| JP (1) | JP2006522779A (en) |
| KR (1) | KR20050115321A (en) |
| CN (1) | CN1795191A (en) |
| AR (1) | AR043941A1 (en) |
| AU (1) | AU2004226207A1 (en) |
| CA (1) | CA2520764A1 (en) |
| EA (1) | EA010403B1 (en) |
| FR (1) | FR2852954B1 (en) |
| HR (1) | HRP20050855A2 (en) |
| RS (1) | RS20050806A (en) |
| TW (1) | TW200505899A (en) |
| WO (1) | WO2004087647A2 (en) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2816618B1 (en) * | 2000-11-15 | 2002-12-27 | Aventis Pharma Sa | HETEROCYCLYLALCOYL PIPERIDINE DERIVATIVES, THEIR PREPARATION AND THE COMPOSITIONS CONTAINING THEM |
| TW200409637A (en) | 2002-06-26 | 2004-06-16 | Glaxo Group Ltd | Compounds |
| TW200406413A (en) | 2002-06-26 | 2004-05-01 | Glaxo Group Ltd | Compounds |
| ATE461928T1 (en) | 2002-11-05 | 2010-04-15 | Glaxosmithkline Llc | ANTIBACTERIAL ACTIVE INGREDIENTS |
| EP1560488B1 (en) | 2002-11-05 | 2010-09-01 | Glaxo Group Limited | Antibacterial agents |
| ATE411312T1 (en) | 2002-12-04 | 2008-10-15 | Glaxo Group Ltd | QUINOLINES AND NITROGEN-CONTAINING DERIVATIVES THEREOF AND THEIR USE AS ANTIBACTERIAL AGENTS |
| GB0326148D0 (en) * | 2003-11-10 | 2003-12-17 | Lilly Co Eli | Morpholine derivatives |
| JP2008502689A (en) | 2004-06-15 | 2008-01-31 | グラクソ グループ リミテッド | Antibacterial agent |
| MY150958A (en) * | 2005-06-16 | 2014-03-31 | Astrazeneca Ab | Compounds for the treatment of multi-drug resistant bacterial infections |
| JP2009532423A (en) | 2006-04-06 | 2009-09-10 | グラクソ グループ リミテッド | Pyrrolo-quinoxalinone derivatives as antibacterial agents |
| EP1992628A1 (en) | 2007-05-18 | 2008-11-19 | Glaxo Group Limited | Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones |
| EP2080761A1 (en) | 2008-01-18 | 2009-07-22 | Glaxo Group Limited | Compounds |
| RU2501799C2 (en) * | 2008-02-22 | 2013-12-20 | Актелион Фармасьютикалз Лтд | Oxazolidinone derivatives |
| EP2352734A1 (en) | 2008-10-17 | 2011-08-10 | Glaxo Group Limited | Tricyclic nitrogen compounds used as antibacterials |
| EP2379554B1 (en) | 2009-01-15 | 2015-11-11 | Glaxo Group Limited | Naphthyridin-2(1h)-one compounds useful as antibacterials |
| AR089929A1 (en) | 2012-02-10 | 2014-10-01 | Actelion Pharmaceuticals Ltd | PROCESS TO MANUFACTURE A NAFTIRIDINE DERIVATIVE |
| US10702521B2 (en) | 2014-08-22 | 2020-07-07 | Glaxosmithkline Intellectual Property Development Limited | Methods for treating neisseria gonorrhoeae infection with substituted 1,2-dihydro-2A,5,8A-triazaacenaphthylene-3,8-diones |
| TW201722965A (en) | 2015-08-16 | 2017-07-01 | 葛蘭素史密斯克藍智慧財產發展有限公司 | Compounds for use in antibacterial applications |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9917408D0 (en) * | 1999-07-23 | 1999-09-22 | Smithkline Beecham Plc | Compounds |
| GB0012240D0 (en) * | 2000-05-19 | 2000-07-12 | Merck Sharp & Dohme | Therapeutic agents |
| FR2816618B1 (en) * | 2000-11-15 | 2002-12-27 | Aventis Pharma Sa | HETEROCYCLYLALCOYL PIPERIDINE DERIVATIVES, THEIR PREPARATION AND THE COMPOSITIONS CONTAINING THEM |
| WO2002055516A2 (en) * | 2001-01-11 | 2002-07-18 | Bristol Myers Squibb Co | 1,1-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLOPROTEASE AND TNF-$g(a) |
-
2003
- 2003-03-28 FR FR0303812A patent/FR2852954B1/en not_active Expired - Fee Related
-
2004
- 2004-03-22 TW TW093107677A patent/TW200505899A/en unknown
- 2004-03-26 AR ARP040101023A patent/AR043941A1/en not_active Application Discontinuation
- 2004-03-29 AU AU2004226207A patent/AU2004226207A1/en not_active Abandoned
- 2004-03-29 CA CA002520764A patent/CA2520764A1/en not_active Abandoned
- 2004-03-29 KR KR1020057018388A patent/KR20050115321A/en not_active Ceased
- 2004-03-29 EP EP04742385A patent/EP1611127A2/en not_active Withdrawn
- 2004-03-29 HR HR20050855A patent/HRP20050855A2/en not_active Application Discontinuation
- 2004-03-29 WO PCT/FR2004/000783 patent/WO2004087647A2/en not_active Ceased
- 2004-03-29 RS YUP-2005/0806A patent/RS20050806A/en unknown
- 2004-03-29 JP JP2006505763A patent/JP2006522779A/en active Pending
- 2004-03-29 CN CNA2004800145109A patent/CN1795191A/en active Pending
- 2004-03-29 EA EA200501526A patent/EA010403B1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EA010403B1 (en) | 2008-08-29 |
| KR20050115321A (en) | 2005-12-07 |
| EA200501526A1 (en) | 2006-04-28 |
| EP1611127A2 (en) | 2006-01-04 |
| AU2004226207A1 (en) | 2004-10-14 |
| CA2520764A1 (en) | 2004-10-14 |
| RS20050806A (en) | 2007-12-31 |
| TW200505899A (en) | 2005-02-16 |
| FR2852954A1 (en) | 2004-10-01 |
| JP2006522779A (en) | 2006-10-05 |
| WO2004087647A3 (en) | 2005-01-27 |
| HRP20050855A2 (en) | 2005-12-31 |
| FR2852954B1 (en) | 2006-07-14 |
| CN1795191A (en) | 2006-06-28 |
| WO2004087647A2 (en) | 2004-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR043941A1 (en) | DERIVATIVES OF QUINOLINES 4-SUBSTITUTES, THEIR PREPARATION PROCEDURES AND INTERMEDIATES AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| AR034006A1 (en) | DERIVATIVES OF HETEROCICLILALQUIL PIPERIDINA, ITS PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| AR083810A2 (en) | DERIVATIVES OF SUBSTITUTED PIRAZINCARBOXANILIDA OR ITS SALTS | |
| PE20081471A1 (en) | HETEROARYLNITRILE DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS | |
| AR035087A1 (en) | PIRIDIL-ALQUINOS AND PIRIDIL-N-OXIDO-ACTIVE HERBICIDE ALKINES, PROCEDURE FOR PREPARATION, HERBICIDE COMPOSITION AND TO INHIBIT THE GROWTH OF PLANTS, METHOD FOR CONTROLLING GROWTH OF INDESEABLE PLANTS, AND METHOD OF CREAM INHIBITION | |
| DK1052254T3 (en) | Nitrogen-containing heterocyclic derivatives and drugs thereof | |
| AR064490A1 (en) | CIANO-BENZANILIDES SUBSTITUTED, INTERMEDIARY FOR PREPARATION, A PESTICIATED COMPOSITION THAT UNDERSTANDS AND USES ITSELF IN A METHOD FOR FIGHTING PESTS. | |
| MX301666B (en) | Amide derivatives, process for production of the same, and method for application thereof as insecticide | |
| AR045246A1 (en) | DERIVATIVES OF PIRAZOLIDIN-3,5-DIONA 4-BIFENIL-SUBSTITUTED | |
| EA200800784A1 (en) | PYRIDINE DERIVATIVES AND THEIR APPLICATION FOR THE TREATMENT OF PSYCHOTICAL DISORDERS | |
| AR081778A1 (en) | DERIVATIVES AND HERBICIDES OF 6-ACIL-1,2,4-TRIAZINA-3,5-DIONA | |
| DE60317326D1 (en) | PHENYL ALKANIC ACID AND PHENYLOXYALKANIC DERIVATIVES AS HPPAR ACTIVATORE | |
| AR070998A1 (en) | DERIVATIVES OF NAFTIRIDINE, A PROCEDURE FOR THEIR PREPARATION AND THAT OF ITS SYNTHESIS INTERMEDIARIES, A HERBICIDE COMPOSITION THAT UNDERSTANDS THEM AND A METHOD FOR SELECTLY CONTROLLING WEEDS. | |
| ES2567260T3 (en) | Human phosphatidylinositol 3-kinase delta inhibitors | |
| DK1065204T3 (en) | Bicyclic carbonyl indole compounds as anti-inflammatory / analgesic agents and as COX-2 inhibitors | |
| PE20130684A1 (en) | HEXAFLUOROISOPROPYL CARBAMATE DERIVATIVES AND THEIR PREPARATION | |
| ES2333802T3 (en) | NON-NUCLEIC INHIBITORS OF INVERSE TRANSCRIPT. | |
| AR058094A1 (en) | NNRT INHIBITORS BASED ON PHENYL-ACETAMIDE | |
| AR080531A1 (en) | TRIAZOL DERIVATIVES AS INSECTICIDES | |
| AR069580A1 (en) | PIRIDILMETIL-SULFONAMIDE COMPOUNDS, METHODS AND INTERMEDIARIES FOR THEIR PREPARATION, AN AGRICULTURAL COMPOSITION THAT UNDERSTANDS THEM, A METHOD TO COMBAT PHYTO-PATHOGENIC FUNGI THAT USES THEM, USE OF THESE COMPOUNDS FOR SUCH PURPOSE AND SEEDS. | |
| CO4970752A1 (en) | NEW DERIVATIVES OF ISATIN AND PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH ISATINES | |
| PT1202959E (en) | AMINOBENZOFENONES AS IL-1-BETA AND TNF-ALPHA INHIBITORS | |
| AR013360A1 (en) | DERIVATIVES OF 6-AZAURACIL IL-5 INHIBITORS, PROCEDURE FOR THE PREPARATION, COMPOSITION CONTAINING THEM, PROCEDURE FOR PREPARATION OF THIS COMPOSITION, USE OF SUCH COMPOUND FOR THE MANUFACTURE OF MEDICINES, COMPOSITIONS AND MARKING PROCEDURE OF A RECEPTOR. | |
| PE20050713A1 (en) | NICOTINAMIDE DERIVATIVES AS PDE4 INHIBITORS | |
| AR054725A1 (en) | PIRAZOLOPIRIDINAS AND SALTS OF THE SAME, A PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS, A METHOD FOR PREPARING THEM AND THEIR USE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |